If you are:
FDB Only When Necessary: NO FDA CAT;ART PREG REGISTRY DATA SHOW NO INCREASED RISK FOR MAJOR BIRTH DEFECTS
Absolute Contraindication: AVOID BREASTFEEDING IN HIV POSITIVE WOMEN PER CDC; NOT REC IN HEP B PATIENTS
Giving lamivudine to a child under 12:
management or monitoring precaution: Safety and efficacy not established in pediatrics age less than 3 months.
management or monitoring precaution: Increased risk of pancreatitis in pediatrics with prior antiretroviral nucleoside exposure and other risk factors. Tablet dose form preferred.